For the pharmaceutical and diagnostic industries, Biognosys offers a unique set of capabilities that enables productive collaborations and a short time to results:

• 100,000 human MRM assays directly available for screening
• Optimized serum depletion procedure
• Glycocapture protocols
• Customized sample preparation from any type of tissue or body fluid
• High-throughput, multiplexed measurements
• Quantification of post-translational protein modifications
• Automatic data analysis with probabilistic scoring

As the majority of drug target and biomarker discovery projects can be simplified to the basic question “What is the difference in a protein profile between two types of samples?”, our technology, knowhow and skill can provide you with the most precise answer to it.

Which types of samples to compare is up to you:

• stimulated vs. non-stimulated cells
• wild-type vs. knock-out animals
• normal vs. pathologic tissue
• healthy vs. sick individuals
• therapy responders vs. non-responders, etc.

By collaborating with us, you will obtain a validated dataset that allows you to not only to generate a hypothesis for a new drug target or biomarker, but also significantly increase the success rate of all subsequent experiments and trials.

If you are interested in establishing your own MRM proteomics capabilities using our technology and knowhow, check the “Technology transfer” section of our site or talk to us.